Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1974 Jun;71(6):2217–2221. doi: 10.1073/pnas.71.6.2217

Location of an Isoproterenol-Responsive Cyclic AMP Pool in Adrenergic Nerve Cell Bodies and Its Relationship to Tyrosine 3-Monooxygenase Induction

U Otten 1, R A Mueller 1,*, F Oesch 1, H Thoenen 1
PMCID: PMC388422  PMID: 4152247

Abstract

To decide whether adenosine 3′:5′-cyclic monophosphate (cyclic AMP) plays a role as a second messenger in the trans-synaptic induction of tyrosine 3-monooxygenase (EC 1.14.16.2), it is desirable to discriminate between neuronal and extraneuronal changes in cyclic AMP concentration. Treatment of newborn rats with nerve growth factor antiserum or 6-hydroxydopamine, leading to destruction of 61-85% of the adrenergic nerve cell bodies in the superior cervical ganglion, led to a decrease in cyclic AMP of only 16-28%. This observation demonstrates that a relatively small portion of cyclic AMP is localized in the adrenergic neurons. However, administration of isoproterenol produced an increase (12-fold) in cyclic AMP only in this neuronal pool. Neither single nor repeated injections of isoproterenol led to induction of tyrosine monoxygenase. This, together with previous observations that experimental conditions leading to induction of the enzyme do not produce significant increases of cyclic AMP in the whole ganglion, is taken as an indication that cyclic AMP is not acting as a second messenger in the trans-synaptic induction of tyrosine monooxygenase in the rat superior cervical ganglion. In the rat adrenal medulla, treatment with reserpine led to both a shortlasting (60-90 min) increase in cyclic AMP and a subsequent induction of tyrosine monooxygenase. However, the increase in cyclic AMP was almost completely prevented (40 compared to 320%) by pretreatment of the rats with propranolol while the induction of tyrosine monooxygenase was not diminished. This observation also argues against an exclusive key-function of cyclic AMP in trans-synaptic induction of tyrosine monooxygenase in the adrenal medulla.

Keywords: trans-synaptic enzyme regulation, superior cervical ganglion, adrenal medulla, reserpine, propranolol

Full text

PDF
2217

Images in this article

2220Image
on p.2220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angeletti P. U., Levi-Montalcini R. Sympathetic nerve cell destruction in newborn mammals by 6-hydroxydopamine. Proc Natl Acad Sci U S A. 1970 Jan;65(1):114–121. doi: 10.1073/pnas.65.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cramer H., Johnson D. G., Hanbauer I., Silberstein S. D., Kopin I. J. Accumulation of adenosine 3',5'-monophosphate induced by catecholamines in the rat superior cervical ganglion in vitro. Brain Res. 1973 Apr 13;53(1):97–104. doi: 10.1016/0006-8993(73)90769-5. [DOI] [PubMed] [Google Scholar]
  3. D'Armiento M., Johnson G. S., Pastan I. Regulation of adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentrations of cyclic adenosine monophosphate (3T3-dibutyryl cyclic AMP-SV40-transformed cells-michaelis constants-L cells-prostaglandin E 1 ). Proc Natl Acad Sci U S A. 1972 Feb;69(2):459–462. doi: 10.1073/pnas.69.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fisch H. U., Pliska V., Schwyzer R. A covalent protein-sepharose complex for the specific adsorption and assay of adenosine 3':5'-monophosphate. Eur J Biochem. 1972 Oct 17;30(1):1–6. doi: 10.1111/j.1432-1033.1972.tb02064.x. [DOI] [PubMed] [Google Scholar]
  5. Greengard P., McAfee D. A. Adenosine 3':5'-cyclic monophosphate as a mediator in the action of neurohumoral agents. Biochem Soc Symp. 1972;(36):87–102. [PubMed] [Google Scholar]
  6. Guidotti A., Costa E. Involvement of adenosine 3',5'-monophosphate in the activation of tyrosine hydroxylase elicited by drugs. Science. 1973 Mar 2;179(4076):902–904. doi: 10.1126/science.179.4076.902. [DOI] [PubMed] [Google Scholar]
  7. Guidotti A., Zivkovic B., Pfeiffer R., Costa E. Involvement of 3',5'-cyclic adenosine monophosphate in the increase of tyrosine hydroxylase activity elicited by cold exposure. Naunyn Schmiedebergs Arch Pharmacol. 1973;278(2):195–206. doi: 10.1007/BF00500650. [DOI] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Levitt M., Gibb J. W., Daly J. W., Lipton M., Udenfriend S. A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol. 1967 Jul 7;16(7):1313–1321. doi: 10.1016/0006-2952(67)90162-1. [DOI] [PubMed] [Google Scholar]
  10. Mackay A. V., Iversen L. L. Increased tyrosine hydroxylase activity of sympathetic ganglia cultured in the presence of dibutyryl cyclic AMP. Brain Res. 1972 Dec 24;48:424–426. doi: 10.1016/0006-8993(72)90204-1. [DOI] [PubMed] [Google Scholar]
  11. Maganiello V., Vaughan M. Prostaglandin E 1 effects on adenosine 3':5'-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts (mouse L cells-tissue culture-enzyme kinetics-prostaglandin homologues). Proc Natl Acad Sci U S A. 1972 Jan;69(1):269–273. doi: 10.1073/pnas.69.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McAfee D. A., Schorderet M., Greengard P. Adenosine 3',5'-monophosphate in nervous tissue: increase associated with synaptic transmission. Science. 1971 Mar 19;171(3976):1156–1158. doi: 10.1126/science.171.3976.1156. [DOI] [PubMed] [Google Scholar]
  13. Molinoff P. B., Axelrod J. Biochemistry of catecholamines. Annu Rev Biochem. 1971;40:465–500. doi: 10.1146/annurev.bi.40.070171.002341. [DOI] [PubMed] [Google Scholar]
  14. Molinoff P. B., Brimijoin S., Weinshilboum R., Axelrod J. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A. 1970 Jun;66(2):453–458. doi: 10.1073/pnas.66.2.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mueller R. A., Thoenen H., Axelrod J. Increase in tyrosine hydroxylase activity after reserpine administration. J Pharmacol Exp Ther. 1969 Sep;169(1):74–79. [PubMed] [Google Scholar]
  16. Mueller R. A., Thoenen H., Axelrod J. Inhiition of neuronally induced tyrosine hydroxylase by nitinic receptor blockade. Eur J Pharmacol. 1970 Apr;10(1):51–56. doi: 10.1016/0014-2999(70)90156-1. [DOI] [PubMed] [Google Scholar]
  17. Patrick R. L., Kirshner N. Acetylcholine-induced stimulation of catecholamine recovery in denervated rat adrenals after reserpine-induced depletion. Mol Pharmacol. 1971 Jul;7(4):389–396. [PubMed] [Google Scholar]
  18. Schultz J., Daly J. W. Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. 3. Formation, degradation, and reformation of cyclic adenosine 3',5'-monophosphate during sequential stimulations by biogenic amines and adenosine. J Biol Chem. 1973 Feb 10;248(3):860–866. [PubMed] [Google Scholar]
  19. Thoenen H., Mueller R. A., Axelrod J. Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission. Nature. 1969 Mar 29;221(5187):1264–1264. doi: 10.1038/2211264a0. [DOI] [PubMed] [Google Scholar]
  20. Thoenen H. Neuronally mediated enzyme induction in adrenergic neurons and adrenal chromaffin cells. Biochem Soc Symp. 1972;(36):3–15. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES